20722-53-6

Usage

Uses

Used in Organic Synthesis:
DMPPM is utilized as an intermediate in the synthesis of organic compounds, contributing to the formation of complex molecular structures and facilitating various chemical reactions.
Used in Pharmaceutical Synthesis:
As a component in the development of pharmaceuticals, DMPPM aids in the creation of new drugs and medicines, potentially enhancing treatment options for various health conditions.
Used in Organic Chemistry as a Reagent:
DMPPM serves as a reagent in organic chemistry, specifically for the formation of carbon-carbon and carbon-nitrogen bonds, which are crucial for constructing a wide range of organic molecules.
Used in Medicinal Chemistry:
Due to its structural similarity to bioactive compounds, DMPPM holds potential for use in medicinal chemistry. While its specific biological activities and therapeutic applications are still under investigation, it may contribute to the discovery of new pharmaceutical agents in the future.

Upstream product

• 98-88-4 benzoyl chloride 
• 504-03-0 2.6-dimethylpiperidine 

Downstream Products

• 61485-85-6 2,6-dibromoheptane 
• 100-47-0 benzonitrile 
• 92321-27-2 2,6-dimethyl-N-benzylpiperidine 

Relevant academic research and scientific papers

A Manganese Pre-Catalyst: Mild Reduction of Amides, Ketones, Aldehydes, and Esters

A new (N-phosphinoamidinate)manganese complex is shown to be a useful pre-catalyst for the hydrosilative reduction of carbonyl compounds, and in most cases at room temperature. The Mn-catalyzed reduction of tertiary amides to tertiary amines, with a useful scope, is demonstrated for the first time by use of this catalyst, and is competitive with the most effective transition-metal catalysts known for such transformations. Ketones, aldehydes, and esters were also successfully reduced under mild conditions by using this new Mn catalyst.

A Convenient Synthetic Route to Methylated Silacyclohexanes

The von Braun degradation of substituted piperidines is a general and economical route to a variety of substituted primary and secondary α,ω-dibromopentanes.Grignard ring closure procedures have been carried out with seven different dibromopentanes in moderate to good yields.Ring closures with MeClSiCl2 lead to product mixtures which are appreciably enriched in one isomer, affording a convenient entry into a variety of derivatives which can be used for stereochemical studies.Assignment of structures based on 1H NMR and mass spectral fragmentation patterns is discussed